Curia recognized for its Service in the CDMO industry 2024 CDMO Leadership Award Curia Receives 2024 CDMO Leadership Award in the Service category. ALBANY, N.Y., Feb. 05, 2024 (GLOBE NEWSWIRE) — Curia, a leading contract research, development and manufacturing organization,

Curia est ainsi reconnue pour son service dans le secteur des organisations de développement et de fabrication sous contrat ALBANY, New York, 05 févr. 2024 (GLOBE NEWSWIRE) — Curia, une organisation de développement et de fabrication sous contrat (CDMO) de

Curia reconhecida pelo seu serviço na indústria de CDMO ALBANY, N.Y., Feb. 05, 2024 (GLOBE NEWSWIRE) — A Curia, uma organização líder em pesquisa, desenvolvimento e fabricação por contrato, anunciou hoje que recebeu um Prêmio de Liderança CDMO 2024 na

Researchers at KFSH&RC & KAUST Discover Gene Responsible for Reproduction of the Most Dangerous Malaria Strain King Faisal Specialist Hospital and Research Center – Riyadh RIYADH, Saudi Arabia, Feb. 05, 2024 (GLOBE NEWSWIRE) — In a major scientific breakthrough, a

Rancho Santa Margarita, Calif., Feb. 05, 2024 (GLOBE NEWSWIRE) — Blue California, an industry leader in science-driven ingredient development, announced the successful completion of a groundbreaking human clinical trial of ergothioneine. A double-blinded placebo-controlled clinical trial sponsored by Blue California